Wheatland Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wheatland Advisors's BMY Position: Q1 2020 in Review
Wheatland Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 9,420 shares — an estimated $605K sold.
Wheatland Advisors first reported a position in BMY in Q4 2013 and held it in 25 quarters. The position peaked at $2.27M in Q2 2016. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.
- Wheatland Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
- Wheatland Advisors sold 9,420 Bristol-Myers Squibb shares in Q1 2020, an estimated $605K.
- Wheatland Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 25 quarters.
- Wheatland Advisors's Bristol-Myers Squibb position peaked at $2.27M in Q2 2016.
- 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.
Based on Wheatland Advisors's 13F filing for Q1 2020, filed 8 May 2020.